期刊文献+

外周神经母细胞性肿瘤的临床病理学观察 被引量:7

Clinicopathologic features of peripheral neuroblastic tumors
原文传递
导出
摘要 目的探讨外周神经母细胞性肿瘤(pNT)的临床、病理特点,分析这些因素在判断肿瘤预后中的作用。方法收集121例儿章pNT的临床、病理及随访资料,依据神经母细胞瘤病理国际分类(INPC),对年龄、临床分期、病理学分型、核分裂一核碎裂指数(MKI)进行单因素预后分析。结果(1)121例患儿,中位年龄2.7岁,年龄〈5岁者96例(79.3%)。(2)神经母细胞瘤(NB)82例;混杂型节细胞性神经母细胞瘤(GNBi)9例;节细胞神经瘤(GN)19例,均为即将成熟型;结节型节细胞性神经母细胞瘤(GNBn)11例。预后良好的组织学类型(FH)49例,预后不良的组织学类型(UH)72例。,(3)121例pNT患儿3年无瘤生存率为(73.0±4.3)%。3年无瘤生存率与患儿年龄(P=0.002)、Evan分期(P=0.000)、病理学分型(P=0.000)、MKI(P=0.043)及组织学预后分组(P=0.000)相关。结论(1)pNT多见于5岁以下儿章,它包括NB、GNBi、GN及GNBn4种类型。(2)pNT3年无瘤生存率约70%,年龄、临床分期、病理学分型及MKI均是判断其预后的指标,INPC是切实可行的分类方法。 Objective To study the clinicopathologic characteristics of peripheral neuroblastic tumors and to evaluate the prognostic significance of these features. Methods The clinical and pathologic findings were retrospectively reviewed in 121 cases of peripheral neuroblastic tumor. The clinical outcomes of patients were evaluated. The three-year event-free survival rate was analyzed, with respect to age of patients, Evan's staging, International Neuroblastoma Pathology Classification and nfitosis-karyorrhexis index. Results The median age at diagnosis was 2.7 years; and 96 cases (79. 3% ) occurred in patients younger than 5 years old. The number of cases in Evan's staging I ,Ⅱ , Ⅲ , Ⅳ and IVs was 24, 39, 24, 29 and 5, respectively. There were 82 cases of neuroblastoma (NB) (including 2 cases of undifferentiated NB, 52 cases of poorly differentiated NB and 28 cases of differentiating NB) , 9 cases of ganglioneuroblastoma, intermixed type (GNBi), 19 cases of ganglioneuroma, maturing type (GN) and 11 cases of ganglioneuroblastoma, nodular type (GNBn). Forty-nine cases were in the favorable histology subgroup and 72 cases in the unfavorable histology subgroup. The overall three-year event-free survival rate of the 121 cases was 73.0%± 4. 3%. The three-year event-free survival rates were associated with age (P = 0. 002 ), Evan's staging ( P = 0. 000 ), histologic category ( P = 0. 000 ), mitosis-karyorrhexis index ( P = 0. 043 ) , prognostic subgroup ( P = 0. 000). Conclusions Most of the peripheral neuroblastic tumors occur in the children younger than 5 years old. It is composed of NB, GNBi, GN and GNBn. The three-year event-free survival rate is approximately 70%. Significant prognostic parameters include age of patients, Evan's staging, International Neuroblastoma Pathology Classification and mitosis-karyorrhexis index.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2013年第5期305-310,共6页 Chinese Journal of Pathology
关键词 神经母细胞瘤 儿童 预后 无病生存 Neuroblastoma Child Prognosis Disease-free survival
  • 相关文献

参考文献23

  • 1Miller RW, Young JL Jr, Novakovic B. Childhood cancer.Cancer,1995, 75( 1 Suppl) :39505.
  • 2Ishola TA, Chung DHI Neuroblastoma. Surg Oncol, 2007, 16 (3) :149-156.
  • 3Brodeur GM, Maris JM. Neuroblastoma//Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott-Raven, 2001 : 895-937.
  • 4Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet, 2007, 369(9579):2106-2120.
  • 5Umehara S, Nakagawa A, Matthay KK, et al. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer, 2000, 89 (5) : 1150-1161.
  • 6Kleihues P, Cavenee WK. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.
  • 7Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastonm Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer, 2003, 98 (10) : 2274- 2281.
  • 8Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer, 1999, 86(2) : 364-372.
  • 9Stocker JT, Dehner LP, Husain AN. Stocker and Dehner's pediatric pathology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2010: 957-968.
  • 10殷敏智,张忠德,马靖,沈萍,陈洁枫,张惠箴.外周神经母细胞性肿瘤135例分类与预后的关系[J].中华病理学杂志,2011,40(3):151-155. 被引量:11

二级参考文献16

  • 1汤静燕,潘慈,陈静,徐敏,薛惠良,顾龙君,董茹,叶辉,周敏,王耀平.45例儿童神经母细胞瘤预后因素分析[J].中华儿科杂志,2006,44(10):770-773. 被引量:21
  • 2Ahungoz O, Aygun N, Tumer S, et al. Correlation of modified Shimada classification with MYCN and lp36 status detected by fluorescence in situ hybridization in neuroblastoma. Cancer Genet Cytogenet, 2007, 172 ( 2 ) : 113-119.
  • 3Dehner LP. Peripheral and central primitive neuroectodermal tumors. A nosologie concept seeking a consensus. Arch Pathol Lab Med, 1986, 110(11):997-1005.
  • 4Pizzo AP, Poplack DG. Principles and practice of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins, 2006.
  • 5Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst, 1984, 73 (2) :405-416.
  • 6Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system ). Cancer, 1999, 86(2) : 364-372.
  • 7Shimada H, Ambros IM, Dehner LP, et ah Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer, 1999, 86(2): 349-363.
  • 8Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer, 2003, 98 (10) : 2274- 2281.
  • 9Shimada H, Umehara S, Monobe Y, et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer, 2001, 92(9) : 2451-2461.
  • 10Goto S, Umehara S, Gerbing RB, et al. Histopathology ( International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors : a report from the Children' s Cancer Group. Cancer, 2001, 92 (10) : 2699- 2708.

共引文献10

同被引文献78

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部